Experienced in leading fast-growing teams and scaling up organizations from a customer-centric perspective, Steven joined UgenTec from Agilent Technologies where he was responsible for strategy and operations leading the genomics software group. Steven previously led operations at the Belgian genomics software company Cartagenia as COO and built out an international delivery organization as VP of Professional Services for BAE Systems Detica.
Wouter founded UgenTec with Tom Martens in 2014 with a plan to become the leading global PCR software company for routine molecular diagnostics. Wouter is an entrepreneur with a solid foundation in bioinformatics and a big passion for life science and the digital revolution in society.
Michiel manages the global sales team from UgenTec. Michiel is a strong business development professional who brings deep molecular dx domain expertise from his previous experiences at life sciences, AgBio and bioinformatics companies including PerkinElmer, Rijk Zwaan, and Genalice.
Steven brings experience in bioinformatics, Artificial Intelligence and Software Marketing from previous roles as scientific founder of genomics software company Cartagenia and head of the product marketing team Genomics Software at Agilent Technologies. Steven built molecular diagnostics experience at the Center for Human Genetics in Leuven and the Sanger institute in Cambridge, UK.
Annie Vereecken is an experienced biotech investor who started as an entrepreneur in gynecological endocrinology and pathology. She built a business in clinical labs acquired by Sonic Healthcare in 2010. Annie actively invests in life sciences companies, including Argenx, Biocartis, MyCartis, Cartagenia (acquired by Agilent Technologies), PharmaFluidics, and Ugentec.
Tom Aerts is head of Smart Services & Manufacturing at investment company LRM, with a strong focus on solutions and technology that accelerate growth and expansion. To this end, LRM has been investing significantly in Technology & Services over the past years. Tom draws domain knowledge and rich experience from board memberships in the health and technology space.
Ivo Marechal is a founding partner at Down 2 earth capital an independent private equity fund that focuses on small and SME equity transactions in Belgium. D2E Capital combines successful private equity experience with a top level industry expertise, and relies on a large network of CEOs and entrepreneurs. Ivo Marechal has held director, CEO and board positions at companies including Overpelt-Plascobel and Essers.
Our company is agile, fast-paced and always looking for new people to join the ranks